Back to all companies
Sign in
Back to all companies
10x Science logo

10x Science

Winter 2026Active

The AI-native platform for next-generation protein characterization.

Save
10x Science logo

10x Science

Winter 2026Active

The AI-native platform for next-generation protein characterization.

Save
Company details

10x Science develops frontier AI models with deep memory to redefine how scientists understand and engineer biology across the life sciences, starting with drug development.

AI-powered drug discovery is flooding the pipeline with new candidates faster than ever. But before any of them can advance to the clinic, scientists must deeply characterize the protein therapeutic to understand whether it will work. Today, that process takes months of manual, error-prone analysis that cannot keep pace with discovery. Our AI-native platform automates it, giving drug developers the confidence to advance the right candidates and stop the wrong ones early.

We have strong commercial traction with enterprise pharma customers. Our founding team built the field of next-generation protein characterization out of Carolyn Bertozzi's Nobel laureate lab at Stanford. Collectively, we have 18+ years of collective domain expertise, 47+ scientific publications, and a 2x YC Founder. We move at the highest velocity and are positioned to lead the next generation of modern AI development in the life sciences.

Location
San Francisco, CA, USA
Founded
Unknown
Category
SaaS
YC Directory Page10xscience.com
Founders
  • DR
    David Roberts
    Founder and CEO
    X / TwitterLinkedIn
  • AR
    Andrew Reiter
    Founder and COO
    LinkedIn
  • VT
    Vishnu Tejus
    Founder and CTO
    X / TwitterLinkedIn

10x Science develops frontier AI models with deep memory to redefine how scientists understand and engineer biology across the life sciences, starting with drug development.

AI-powered drug discovery is flooding the pipeline with new candidates faster than ever. But before any of them can advance to the clinic, scientists must deeply characterize the protein therapeutic to understand whether it will work. Today, that process takes months of manual, error-prone analysis that cannot keep pace with discovery. Our AI-native platform automates it, giving drug developers the confidence to advance the right candidates and stop the wrong ones early.

We have strong commercial traction with enterprise pharma customers. Our founding team built the field of next-generation protein characterization out of Carolyn Bertozzi's Nobel laureate lab at Stanford. Collectively, we have 18+ years of collective domain expertise, 47+ scientific publications, and a 2x YC Founder. We move at the highest velocity and are positioned to lead the next generation of modern AI development in the life sciences.

Location
San Francisco, CA, USA
Founded
Unknown
Category
SaaS
YC Directory Page10xscience.com
Founders
  • DR
    David Roberts
    Founder and CEO
    X / TwitterLinkedIn
  • AR
    Andrew Reiter
    Founder and COO
    LinkedIn
  • VT
    Vishnu Tejus
    Founder and CTO
    X / TwitterLinkedIn
Pro

Upgrade to Pro, then request the 10x Science teardown.

This company does not have a completed analysis yet. Choose a Pro plan first, then use one of your 5 monthly research requests to have our agent investigate 10x Science. The full teardown, rebuild plan, and technical specs unlock when it lands.

  • Use Pro to request the first 10x Science teardown and keep the finished report in your account.
  • Read every completed teardown and rebuild plan already in the database.
  • Unlock implementation-ready technical specs and 5 fresh research requests each month.

Choose your Pro plan

$20/ month

Find one worth rebuilding, get the teardown, open the implementation-ready specs, and use fresh report requests when you want deeper research.

See Pro plans
Full teardown library
Specs for every company
5 fresh requests / month
CLI for agent imports
Startups.RIP — Dead startups, alive ideas
PricingContactPrivacyGot feedback? DM @oscrhong